Association of eNOS Glu298Asp gene polymorphism with circadian blood pressure rhythm

Journal of Human Hypertension

Volumn 21, Issue 6, 2007, Pages 501-503

  Ormezzano, O ^a   Amar, J ^b   Vehier Mounier, C ^c   Cambien, F ^d   Poirier, O ^d   Chamontin, B ^b   Francois P ^a   Mallion, J M ^a   Baguet, J P ^a  

^a HÔPITAL MICHALLON   (France)

^b CHU PURPAN   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE MASS; HEART RATE VARIABILITY; HEART RHYTHM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ASPARTIC ACID; BLOOD PRESSURE; CIRCADIAN RHYTHM; GLUTAMIC ACID; HUMANS; HYPERTENSION; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 34249277091     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002169     Document Type: Article

References (12)

1. Witte K, Schnecko A, Zuther P, Lemmer B. Contribution of the nitric oxide-guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar-Kyoto rats. Cardiovasc Res 1995; 30: 682-688.
2. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002; 20: 2023-2027.
3. Ragot S, Herpin D, Siche JP, Poncelet P, Mallion JM. Relationship between short-term and long-term blood pressure variabilities in essential hypertensives. J Hum Hypertens 2001; 15: 41-48.
4. Passino C, Magagna A, Conforti F, Buralli S, Kozakova M, Palombo C et al. Ventricular repolarization is prolonged in nondipper hypertensive patients: Role of left ventricular hypertrophy and autonomic nervous dysfunction. J Hypertens 2003; 21: 445-451.
5. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A et al. Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 1999; 29: 284-290.
6. Waki H, Kasparov S, Wong LF, Murphy D, Shimizu T, Paton JFR. Chronic inhibition of endothelial nitric oxide synthase activity in nucleus tractus solitarii enhances baroreceptor reflex in conscious rats. J Physiol 2003; 546: 233-242.
7. Van Vliet BN, Chafe LL, Montani JP. Characteristics of 24 h telemetered blood pressure in eNOS-knockout and C57Bl/6J control mice. J Physiol 2003; 549: 313-325.
8. Tuck ML, Stern N, Sowers JR. Enhanced 24-h norepinephrine and renin secretion in young patients with essential hypertension: Relation with the circadian pattern of arterial blood pressure. Am J Cardiol 1985; 55: 112-115.
9. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, Henrion D et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999; 99: 3096-3098.
10. Malhotra S, Poole J, Davis H, Dong Y, Pollock J, Snieder H et al. Effects of NOS3 Glu298Asp polymorphism on hemodynamic reactivity to stress: Influences of ethnicity and obesity. Hypertension 2004; 44: 866-871.
11. Karvonen J, Kauma H, Kervinen K, Rantala M, Ikaheimo M, Paivansalo M et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002; 251: 102-110.
12. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: Meta-analysis of 26 studies involving 23028 subjects. Circulation 2004; 109: 1359-1365.